News | April 02, 2024
Apotex to acquire Canadian Searchlight Pharma
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
The company had earlier announced about the approval received from the MHRA for Liraglutide
Establishment of 220 smart classrooms across Uttar Pradesh, Uttarakhand, and Himachal Pradesh
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Combination shows consistent benefit across prespecified post-progression outcomes
Hepatitis B infects over 40 million people in India
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
The pilot plant is focused on scaling up beverage production and will support applications
Subscribe To Our Newsletter & Stay Updated
